MultiplexDX

MultiplexDX is a Slovak biotechnology company that develops groundbreaking diagnostic solutions for personalized cancer treatment. For example, its flagship test, Multiplex8+, enables more accurate breast cancer diagnosis and the selection of targeted therapies. The company has secured significant investor support as well as an EIC Accelerator grant and aims to become a global leader in precision oncology diagnostics.